India is already a global pharmaceutical leader. The next step is consolidating the regulatory trust that opens the most demanding markets in the world; the US, EU, UK and Japan. Our Mumbai Rephine Connect Live edition has now taken place, but this is only the beginning, more events are on the way.
Our Chief Scientific Officer, Dr Eduard Cayón, distils the main takeaways from the day into a few focused minutes. The fastest way to catch up on what mattered most, and an easy one to share with your team.
